共 50 条
- [21] Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02): : 353 - 360
- [26] Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: Military Considerations CUTIS, 2022, 110 (06): : 316 - 320